Natco pharma Limited has submitted its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, demonstrating adherence to regulatory requirements for securities dematerialization and depository management.

Regulatory Filing Details

The pharmaceutical company filed the mandatory certificate with both major stock exchanges on April 8, 2026. Company Secretary and Compliance Officer Ch. Venkat Ramesh submitted the documentation to BSE Limited and National Stock Exchange of India Limited, fulfilling the quarterly reporting obligations.

Compliance Certification

Venture Capital and Corporate Investments Private Limited, serving as the registrar and transfer agent, issued the compliance certificate confirming proper handling of dematerialization processes. The certificate validates that all securities received for dematerialization during the quarter were processed according to regulatory standards.

The registrar certified that securities were mutilated and cancelled after due verification, with depository records updated within the mandatory 15-day timeframe. Both National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) were properly updated as registered owners in the company's records.

Depository Operations

The certificate confirms compliance with key operational requirements:

• Proper verification and cancellation of physical securities
• Timely updating of depository records within 15 days
• Maintenance of accurate ownership records for both NSDL and CDSL
• Furnishing of security details to relevant stock exchanges

Corporate Information

Natco Pharma Limited operates from its registered office at 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad, with CIN L24230TG1981PLC003201. The company maintains its compliance framework through designated officers who ensure adherence to SEBI regulations and stock exchange requirements.

The quarterly filing represents part of the company's ongoing regulatory obligations, ensuring transparency in securities handling and maintaining investor confidence through proper depository management practices.

Natco Pharma Limited has successfully concluded its postal ballot process for the reappointment of four key directors, with results announced on March 25, 2026. The pharmaceutical company conducted the voting process entirely through electronic means, demonstrating strong shareholder support across all proposed resolutions.

Postal Ballot Process Details

The postal ballot was conducted in compliance with Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The comprehensive voting process spanned over a month, with specific timelines established for shareholder participation.

Director Reappointments

All four directors were successfully reappointed with effect from April 1, 2026, following the overwhelming approval from shareholders. The reappointments strengthen the company's leadership continuity and strategic direction.

Voting Results Summary

The postal ballot results demonstrated exceptional shareholder confidence in the company's leadership, with all four special resolutions receiving approval rates exceeding 98%. The voting participation was robust, with significant engagement from both institutional and retail investors.

Resolution-wise Approval Rates

Shareholder Participation Analysis

The voting process witnessed substantial participation across different shareholder categories. Promoter and promoter group shareholders showed unanimous support with 100.00% approval across all resolutions, while institutional and retail investors also demonstrated strong confidence in the proposed reappointments.

Category-wise Voting Pattern

Regulatory Compliance

The postal ballot process was conducted under the supervision of CS Kiran Kumar Bodla of BK & Associates, Company Secretaries, who served as the appointed Scrutinizer. The process adhered to all applicable provisions of the Companies Act, 2013, and SEBI regulations, ensuring transparency and fairness in the voting mechanism. The company utilized the services of National Securities Depository Limited (NSDL) for the electronic voting platform, facilitating seamless shareholder participation.